Cargando…
Development and validation of a risk prediction score for severe acute pancreatitis
INTRODUCTION: The available prognostic scoring systems for severe acute pancreatitis (SAP) have limitations that restrict their clinical value. The aim of this study was to develop a simple model (score) that could rapidly identify those at risk for SAP. METHODS: We derived a risk model using a retr...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505180/ https://www.ncbi.nlm.nih.gov/pubmed/31068202 http://dx.doi.org/10.1186/s12967-019-1903-6 |
_version_ | 1783416708402249728 |
---|---|
author | Hong, Wandong Lillemoe, Keith D. Pan, Shuang Zimmer, Vincent Kontopantelis, Evangelos Stock, Simon Zippi, Maddalena Wang, Chao Zhou, Mengtao |
author_facet | Hong, Wandong Lillemoe, Keith D. Pan, Shuang Zimmer, Vincent Kontopantelis, Evangelos Stock, Simon Zippi, Maddalena Wang, Chao Zhou, Mengtao |
author_sort | Hong, Wandong |
collection | PubMed |
description | INTRODUCTION: The available prognostic scoring systems for severe acute pancreatitis (SAP) have limitations that restrict their clinical value. The aim of this study was to develop a simple model (score) that could rapidly identify those at risk for SAP. METHODS: We derived a risk model using a retrospective cohort of 700 patients by logistic regression and bootstrapping methods. The discriminative power of the risk model was assessed by calculating the area under the receiver operating characteristic curves (AUC). The classification and regression tree (CART) analysis was used to create risk categories. The model was internally validated by a tenfold cross-validation and externally validated in a separate prospective cohort of 194 patients. RESULTS: The incidence of SAP was 9.7% in the derivation cohort and 9.3% in the validation cohort. A prognostic score (We denoted it as the SABP score), ranging from 0 to 10, consisting of systemic inflammatory response syndrome, serum albumin, blood urea nitrogen and pleural effusion, was developed by logistic regression and bootstrapping analysis. Patients could be divided into three risk categories according to total SABP score based on CART analysis. The mean probability of developing SAP was 1.9%, 12.8% and 41.6% in patients with low (0–3), moderate (4–6) and high (7–10) SABP score, respectively. The AUCs of prognostic score in tenfold cross-validation was 0.873 and 0.872 in the external validation. CONCLUSION: Our risk prediction score may assist physicians in predicting the development of SAP. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-019-1903-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6505180 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-65051802019-05-10 Development and validation of a risk prediction score for severe acute pancreatitis Hong, Wandong Lillemoe, Keith D. Pan, Shuang Zimmer, Vincent Kontopantelis, Evangelos Stock, Simon Zippi, Maddalena Wang, Chao Zhou, Mengtao J Transl Med Research INTRODUCTION: The available prognostic scoring systems for severe acute pancreatitis (SAP) have limitations that restrict their clinical value. The aim of this study was to develop a simple model (score) that could rapidly identify those at risk for SAP. METHODS: We derived a risk model using a retrospective cohort of 700 patients by logistic regression and bootstrapping methods. The discriminative power of the risk model was assessed by calculating the area under the receiver operating characteristic curves (AUC). The classification and regression tree (CART) analysis was used to create risk categories. The model was internally validated by a tenfold cross-validation and externally validated in a separate prospective cohort of 194 patients. RESULTS: The incidence of SAP was 9.7% in the derivation cohort and 9.3% in the validation cohort. A prognostic score (We denoted it as the SABP score), ranging from 0 to 10, consisting of systemic inflammatory response syndrome, serum albumin, blood urea nitrogen and pleural effusion, was developed by logistic regression and bootstrapping analysis. Patients could be divided into three risk categories according to total SABP score based on CART analysis. The mean probability of developing SAP was 1.9%, 12.8% and 41.6% in patients with low (0–3), moderate (4–6) and high (7–10) SABP score, respectively. The AUCs of prognostic score in tenfold cross-validation was 0.873 and 0.872 in the external validation. CONCLUSION: Our risk prediction score may assist physicians in predicting the development of SAP. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-019-1903-6) contains supplementary material, which is available to authorized users. BioMed Central 2019-05-08 /pmc/articles/PMC6505180/ /pubmed/31068202 http://dx.doi.org/10.1186/s12967-019-1903-6 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Hong, Wandong Lillemoe, Keith D. Pan, Shuang Zimmer, Vincent Kontopantelis, Evangelos Stock, Simon Zippi, Maddalena Wang, Chao Zhou, Mengtao Development and validation of a risk prediction score for severe acute pancreatitis |
title | Development and validation of a risk prediction score for severe acute pancreatitis |
title_full | Development and validation of a risk prediction score for severe acute pancreatitis |
title_fullStr | Development and validation of a risk prediction score for severe acute pancreatitis |
title_full_unstemmed | Development and validation of a risk prediction score for severe acute pancreatitis |
title_short | Development and validation of a risk prediction score for severe acute pancreatitis |
title_sort | development and validation of a risk prediction score for severe acute pancreatitis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505180/ https://www.ncbi.nlm.nih.gov/pubmed/31068202 http://dx.doi.org/10.1186/s12967-019-1903-6 |
work_keys_str_mv | AT hongwandong developmentandvalidationofariskpredictionscoreforsevereacutepancreatitis AT lillemoekeithd developmentandvalidationofariskpredictionscoreforsevereacutepancreatitis AT panshuang developmentandvalidationofariskpredictionscoreforsevereacutepancreatitis AT zimmervincent developmentandvalidationofariskpredictionscoreforsevereacutepancreatitis AT kontopantelisevangelos developmentandvalidationofariskpredictionscoreforsevereacutepancreatitis AT stocksimon developmentandvalidationofariskpredictionscoreforsevereacutepancreatitis AT zippimaddalena developmentandvalidationofariskpredictionscoreforsevereacutepancreatitis AT wangchao developmentandvalidationofariskpredictionscoreforsevereacutepancreatitis AT zhoumengtao developmentandvalidationofariskpredictionscoreforsevereacutepancreatitis |